histone lysine methyltransferase G9a/GLP inhibitors (Daiichi Sankyo)

N/A

Report date: 2025/03/20 15:19:41
NME

Base Information

Drug Namehistone lysine methyltransferase G9a/GLP inhibitors (Daiichi Sankyo)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEuchromatic Histone Lysine Methyltransferase 1 inhibitorsHistone-lysine N-methyltransferase EHMT2 inhibitors
TargetsHistone-lysine N-methyltransferase EHMT2Euchromatic Histone Lysine Methyltransferase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaiichi Sankyo Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A